| Literature DB >> 27104178 |
Byoung-Wook Cho1, Seung-Eun Kwon1, Soon-Ki Kim1, Taek Lee2, Jee-Young Han3, Ji-Eun Lee1.
Abstract
Klinefelter syndrome (KS) is one of the most common disease entities characterized by X-chromosomal aberration causing the primary hypogonadism in adult men. Patients with KS seem to be typically characterized by tall, slender bodies with delayed puberty and hypergonadotropic hypogonadism. However, it has been known that they have a broad spectrum of phenotype ranging from almost normal external appearances to typical phenotype. Only 25% KS Patients are ever diagnosed because KS remains unrecognized. Also, boys with KS have an onset of pubertal development within the normal range, not delayed onset of puberty. Adolescents with KS are generally diagnosed as having the lack of pubertal progress. Early detection of KS can be difficult without awareness. We report an unusual case of early onset of puberty in obese boy with KS who presented with a unilateral non-hormone secreting testicular teratoma.Entities:
Keywords: Child; Klinefelter syndrome; Puberty
Year: 2016 PMID: 27104178 PMCID: PMC4835560 DOI: 10.6065/apem.2016.21.1.39
Source DB: PubMed Journal: Ann Pediatr Endocrinol Metab ISSN: 2287-1012
Fig. 1(A) Resected left testicular mass revealed a mature teratoma. The nodule in the testis showed mature squamous cell nests in the fibrotic stroma (H&E, ×200). (B) The testicular parenchyme showed atrophic seminiferous tubule without germ cells. The hyperplastic Leydig cells were noted (H&E, ×200).
Results of LHRH stimulating test of the patient
| Basal | 30 Minutes | 45 Minutes | 60 Minutes | |
|---|---|---|---|---|
| LH (mIU/mL) | 15.30 | 81.10 | 70.50 | 59.80 |
| FSH (mIU/mL) | 45.30 | 77.70 | 84.20 | 87.60 |
LHRH, luteinizing hormone-releasing hormone; FSH, follicle stimulating hormone.
Laboratory characteristics of the patient
| Characteristic | Initial | After 2.5 years | Normal range |
|---|---|---|---|
| LH (mIU/mL) | 15.30 | 7.94 | 0–1.4 |
| FSH (mIU/mL) | 45.30 | 20.88 | 0.1–2.3 |
| Testosterone (ng/mL) | 1.35 | 2.47 | 2.67–10.12 |
| DHEA-S (ug/dL) | 59.4 | 143.3 | 80.0–560.0 |
| Estradiol (pg/mL) | 46.51 | 36.56 | 5.0–16.0 |
| Prolactin (ng/mL) | 8.12 | - | 1.80–15.90 |
| IGF-1 (ng/mL) | 441.1 | - | 169.0–395.0 |
| IGFBP-3 (ng/mL) | 3918 | - | 1,433–4354 |
| TSH (mIU/L) | 0.73 | 2.32 | 0.17–4.85 |
| Free T4 (ng/dL) | 1.34 | 1.41 | 0.80–1.90 |
| Fasting glucose (mg/dL) | 72 | 97 | 70–100 |
| Fasting Insulin (uU/mL) | 13.70 | 17.59 | 4.00–16.00 |
| HbA1C (%) | 6.0 | 5.8 | 4.0–6.0 |
LH, luteinizing hormone; FSH, follicle stimulating hormone; DHEA-S, dehydroepiandrosterone-sulfate; IGF-1, insulin-like growth factor-I; IGFBP-3, IGF binding protein-3; TSH, thyroid-stimulating hormone; HbA1C, glycosylated hemoglobin.